4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:原厂直采,平行进口,授权代理(蚂蚁淘为您服务)
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > juhewu > 中生物/甲型H1N1流感(A/波多黎各/8/34/西奈山)核蛋白/NP(I116M)蛋白(ECD,His-Tag)/1/11675-V08B
商品详细中生物/甲型H1N1流感(A/波多黎各/8/34/西奈山)核蛋白/NP(I116M)蛋白(ECD,His-Tag)/1/11675-V08B
中生物/甲型H1N1流感(A/波多黎各/8/34/西奈山)核蛋白/NP(I116M)蛋白(ECD,His-Tag)/1/11675-V08B
中生物/甲型H1N1流感(A/波多黎各/8/34/西奈山)核蛋白/NP(I116M)蛋白(ECD,His-Tag)/1/11675-V08B
商品编号: 11675-V08B
品牌: sinobiological
市场价: ¥0.00
美元价: 0.00
产地: 美国(厂家直采)
公司:
产品分类: 聚合物
公司分类: juhewu
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

Influenza A H1N1 (A/Puerto Rico/8/34/Mount Sinai) Nucleoprotein / NP (I116M) Protein (ECD, His Tag): Product Information

Purity
> 97 % as determined by SDS-PAGE
Endotoxin
< 1.0="" eu="" per="" μg="" of="" the="" protein="" as="" determined="" by="" the="" lal="">
Activity
Testing in progress
Protein Construction
A DNA sequence encoding the Influenza A virus (A/Puerto Rico/8/34/Mount Sinai (H1N1)) nucleoprotein (AAM75159.1, with mutation Ile 116 Met) (Met1-Gly490) was fused with a polyhistidine tag at the C-terminus.
Accession#
AAM75159.1
Expressed Host
Baculovirus-Insect Cells
Species
H1N1
Predicted N Terminal
Met 1
Molecule Mass
The recombinant Influenza A virus (A/Puerto Rico/8/34/Mount Sinai (H1N1)) nucleoprotein comprises 501 amino acids and has a predicted molecular mass of 56.7 kDa. It migrates as an approximately 50 kDa band in SDS-PAGE under reducing conditions.
Formulation
Lyophilized from sterile 60mM Tris, 500mM NaCl, 10%glycerol, pH 7.5Please contact us for any concerns or special requirements. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the hard copy of CoA.
Shipping
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
Stability & Storage
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution
A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.

Influenza A H1N1 (A/Puerto Rico/8/34/Mount Sinai) Nucleoprotein / NP (I116M) Protein (ECD, His Tag): Images

H1N1 Nucleoprotein Protein 9692

Influenza A H1N1 (A/Puerto Rico/8/34/Mount Sinai) Nucleoprotein / NP (I116M) Protein (ECD, His Tag): Synonyms

NP Protein, H1N1

Nucleocapsid/NP Background Information

Influenza A viral nucleoprotein (NP) plays a critical role in virus replication and host adaptation. The influenza A virus nucleoprotein (NP) is an essential multifunctional protein that encapsidates the viral genome and functions as an adapter between the virus and the host cell machinery. NPs from all strains of influenza A viruses contain two nuclear localization signals (NLSs): a well-studied monopartite NLS1 and a less-characterized NLS2, thought to be bipartite. The nucleocapsid is a complex of the viral nucleoprotein, RNA, and several other viral proteins. The nucleoprotein forms large, RNA-bound, helical filaments and acts as a scaffold for additional viral proteins.

Influenza B Nucleocapsid/NP Proteins

  • Influenza B (B/Florida/4/2006) Nucleoprotein / NP Protein (His Tag)40438-V08B
  • Influenza B (B/Phuket/3073/2013) Nucleoprotein / NP Protein (His Tag)40500-V08B
  • Influenza B (B/Washington/02/2019) Nucleoprotein / NP Protein (His Tag)40755-V08B

H1N1 Nucleocapsid/NP Proteins

  • Influenza A H1N1 (A/Hawaii/70/2019) Nucleoprotein / NP Protein (His Tag)40724-V08B
  • Influenza A H1N1 (A/Brevig Mission/1/1918) Nucleoprotein / NP Protein (His Tag)40204-V08B
  • Influenza A H1N1 (A/Guangdong-Maonan/SWL1536/2019) Nucleoprotein / NP Protein (His Tag)40723-V08B
  • Influenza A H1N1 (A/California/07/2009) Nucleoprotein / NP Protein (His Tag)40205-V08B

H3N2 Nucleocapsid/NP Proteins

  • Influenza A H3N2 (A/Switzerland/9715293/2013) Nucleoprotein / NP Protein (His Tag)40499-V08B
  • Influenza A H3N2 (A/Aichi/2/1968) Nucleoprotein / NP Protein (His Tag)40207-V08B
  • Influenza A H3N2 (A/Hong Kong/2671/2019) Nucleoprotein / NP Protein (His Tag)40753-V08B
  • Influenza A H3N2 (A/Hong Kong/45/2019) Nucleoprotein / NP Protein (His Tag)40754-V08B
  • Influenza A H3N2 (A/Hong Kong/1/1968) Nucleoprotein / NP Protein (His Tag)40208-V08B

H7N9 Nucleocapsid/NP Proteins

  • Influenza A H7N9 (A/Anhui/1-BALF_RG6/2013) Nucleocapsid / NP Protein (His Tag)40110-V08B
  • Influenza A H7N9 (A/Shanghai/2/2013) Nucleocapsid / NP Protein (His Tag)40111-V08B

H2N2 Nucleocapsid/NP Proteins

  • Influenza A H2N2 (A/Ann Arbor/6/1960) Nucleoprotein / NP Protein (His Tag)40033-V08B
  • CONSTRUCTION OF RECOMBINANT ADENOVIRAL VECTOR EXPRESSING GENES OF THE CONSERVATIVE INFLUENZA PROTEINS M2 AND NUCLEOPROTEIN
    Author
    ИБ Есмагамбетов;ЕС Седова;
    Year
    2014
    Journal
    Молекулярная генетика, микробиология и вирусология
    Application
    ELISA
    PubMed ID: 25080815FoldedExpand
  • Evaluating the potential of novel virus-vectored vaccines as intranasal vaccine candidates for broad immunity against influenza
    Author
    Mullin, J;Ahmed, MS;Upile, N;Vaughan, C;
    Year
    2014
    Journal
    University of Liverpool
    FoldedExpand
  • Whole-Virus Screening to Develop Synbodies for the Influenza Virus
    Author
    Gupta, N;Lainson, J;Domenyuk, V;Zhao, ZG;Johnston, SA;Diehnelt, CW;
    Year
    2016
    Journal
    Bioconjug. Chem.
    Application
    SPR
    PubMed ID: 27658460FoldedExpand
  • Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals
    Author
    Henry, C;Zheng, NY;Huang, M;Cabanov, A;Rojas, KT;Kaur, K;Andrews, SF;Palm, AE;Chen, YQ;Li, Y;Hoskova, K;Utset, HA;Vieira, MC;Wrammert, J;Ahmed, R;Holden-Wiltse, J;Topham, DJ;Treanor, JJ;Ertl, HC;Schmader, KE;Cobey, S;Krammer, F;Hensley, SE;Greenberg, H;He, XS;Wilson, PC;
    Year
    2019
    Journal
    Cell Host Microbe
    Application
    ELISA
    PubMed ID: 30795982FoldedExpand
  • Gold nanopillar array with sharp surface plasmon resonances and the application in immunoassay
    Author
    Yanagawa, H;Hinamoto, T;Kanno, T;Sugimoto, H;Shioi, M;Fujii, M;
    Year
    2019
    Journal
    Journal of Applied Physics
    Application
    SPR
    FoldedExpand
  • Tissue-resident CD4+ T helper cells assist protective respiratory mucosal B and CD8+ T cell memory responses
    Author
    Son, YM;Cheon, IS;Wu, Y;Li, C;Wang, Z;Chen, Y;
    Year
    2020
    Journal
    bioRxiv
    Application
    binding
    FoldedExpand
  • Redefining CD4 T cell residency: Helper T cells orchestrate protective humoral immunity in the lung
    Author
    Swarnalekha, N;Schreiner, D;Litzler, LC;Iftikhar, S;
    Year
    2020
    Journal
    bioRxiv
    Application
    ELISpot
    FoldedExpand
  • Magnetic Particle Spectroscopy for Detection of Influenza A Virus Subtype H1N1
    Author
    Wu, K;Liu, J;Saha, R;Su, D;Krishna, VD;Cheeran, MC;Wang, JP;
    Year
    2020
    Journal
    ACS Appl Mater Interfaces
    Application
    binding
    PubMed ID: 32150378FoldedExpand
  • Highly sensitive and universal detection strategy based on a colorimetric assay using target-specific heterogeneous sandwich DNA aptamer
    Author
    Kang, J;Yeom, G;Jang, H;Park, C;Kim, M;
    Year
    2020
    Journal
    Analytica Chimica Acta
    Application
    Elisa
    FoldedExpand

If you couldn"t find the specific citation, you can:

  • Find All Citations
  • Submit a CitationGet a Publication Reward
  • Leave Us a Message

E.coli protein expression service

Mammalian transient protein expression service

Baculovirus-insect expression service

Stable cell line development service (CHO / HEK293)

品牌介绍
北京义翘神州科技股份有限公司(Sino Biological Inc.)是一家从事生物试剂研发、生产、销售并提供技术服务的生物科技公司,主要业务包括重组蛋白、抗体、基因和培养基等产品,以及重组蛋白、抗体的开发和生物分析检测等服务。义翘神州为全球的药品研发企业和生命科学研究机构提供高质量的生物试剂产品和高水平的技术服务。公司目前生产和销售的现货产品种类超过 4.6 万种,其中重组蛋白约 6,000 种,包括超过 3,800 种人源细胞表达重组蛋白产品,能够全面满足客户对于最接近人体天然蛋白结构和性质的重组蛋白需求;公司还能提供约 12,000 种抗体,其中单克隆抗体数量约 4,600 种,能够覆盖生命科学研究的多个领域,为分子生物学、细胞生物学、免疫学、发育生物学、干细胞研究等基础科研方向和创新药物研发提供「一站式」生物试剂产品和技术服务。义翘神州的客户涵盖大学、科研院所、医药研发企业等国内外各类生物研发单位。目前公司已经在美国、欧洲建立了子公司,已成为生物试剂行业国内领先的科技公司之一。